409 related articles for article (PubMed ID: 26462862)
21. Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Mellergård J; Tisell A; Blystad I; Grönqvist A; Blennow K; Olsson B; Dahle C; Vrethem M; Lundberg P; Ernerudh J
Eur J Neurol; 2017 Jan; 24(1):112-121. PubMed ID: 27699930
[TBL] [Abstract][Full Text] [Related]
22. The relationship between ANT1 and NFL with autophagy and mitophagy markers in patients with multiple sclerosis.
Hassanpour M; Cheraghi O; Laghusi D; Nouri M; Panahi Y
J Clin Neurosci; 2020 Aug; 78():307-312. PubMed ID: 32376155
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D as an early predictor of multiple sclerosis activity and progression.
Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Axelsson M; Malmeström C; Gunnarsson M; Zetterberg H; Sundström P; Lycke J; Svenningsson A
Mult Scler; 2014 Jan; 20(1):43-50. PubMed ID: 23702432
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Gaetani L; Eusebi P; Mancini A; Gentili L; Borrelli A; Parnetti L; Calabresi P; Sarchielli P; Blennow K; Zetterberg H; Di Filippo M
Mult Scler Relat Disord; 2019 Oct; 35():228-232. PubMed ID: 31404762
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Qu J; Cookfair D; Duan X; Bang E; Bergsland N; Hussein S; Cherneva M; Willis L; Heininen-Brown M; Ramanathan M
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):189-95. PubMed ID: 21047880
[TBL] [Abstract][Full Text] [Related]
29. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
[TBL] [Abstract][Full Text] [Related]
30. Neurofilament light chain level is a weak risk factor for the development of MS.
Arrambide G; Espejo C; Eixarch H; Villar LM; Alvarez-Cermeño JC; Picón C; Kuhle J; Disanto G; Kappos L; Sastre-Garriga J; Pareto D; Simon E; Comabella M; Río J; Nos C; Tur C; Castilló J; Vidal-Jordana A; Galán I; Arévalo MJ; Auger C; Rovira A; Montalban X; Tintore M
Neurology; 2016 Sep; 87(11):1076-84. PubMed ID: 27521440
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Martin SJ; McGlasson S; Hunt D; Overell J
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141
[TBL] [Abstract][Full Text] [Related]
32. Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis.
Monreal E; Ruiz PD; San Román IL; Rodríguez-Antigüedad A; Moya-Molina MÁ; Álvarez A; García-Arcelay E; Maurino J; Shepherd J; Cabrera ÁP; Villar LM
Front Public Health; 2024; 12():1397845. PubMed ID: 38711771
[TBL] [Abstract][Full Text] [Related]
33. Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal.
Bettencourt A; Boleixa D; Reguengo H; Samões R; Santos E; Oliveira JC; Silva B; Costa PP; da Silva AM
J Steroid Biochem Mol Biol; 2018 Jun; 180():137-141. PubMed ID: 28951256
[TBL] [Abstract][Full Text] [Related]
34. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
Zhang Y; Liu G; Han X; Dong H; Geng J
J Neuroimmunol; 2016 Aug; 297():127-31. PubMed ID: 27397085
[TBL] [Abstract][Full Text] [Related]
35. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
[TBL] [Abstract][Full Text] [Related]
36. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
[TBL] [Abstract][Full Text] [Related]
37. Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
Engel S; Halcour J; Ellwardt E; Uphaus T; Steffen F; Zipp F; Bittner S; Luessi F
Fluids Barriers CNS; 2023 Jan; 20(1):3. PubMed ID: 36631830
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
[TBL] [Abstract][Full Text] [Related]
39. Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS.
Damasceno A; Dias-Carneiro RPC; Moraes AS; Boldrini VO; Quintiliano RPS; da Silva VAPG; Farias AS; Brandão CO; Damasceno BP; Dos Santos LMB; Cendes F
Mult Scler Relat Disord; 2019 May; 30():149-153. PubMed ID: 30772673
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
